Feedback at the forefront of the future of medical communications

Feedback PLC is a specialist medical imaging technology company providing innovative software and systems through its fully owned trading subsidiary, Feedback Medical Limited.

The company’s products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

Feedback Medical work with customers globally from our headquarters in London, UK.

Feedback PLC (AIM:FDBK) announced a placing to raise at least GBP10mln to fund growth opportunities in the National Health Service (NHS) and other healthcare systems in the UK and abroad.

The specialist clinical communication company said the placing is priced at 0.7 pence per share, which is a discount of 11.9% to yesterday’s closing price.

Around 71.42mln new shares will be issued to qualifying shareholders to raise up to a further GBP0.5mln.

The funding proceeds will be used to develop Feedback’s CareLocker product and its Bleepa platform, to accelerate growth in the UK and manage overseas operations, to undertake a tuberculosis screening pilot study in India and to explore wider market opportunities in the country.

() is set to participate in a pilot scheme to provide Community Diagnostic Centre (CDC) services with the Sussex Integrated Care System (ICS).

The pilot scheme, which will be conducted with the Queen Victoria Hospital NHS Foundation Trust (QVH), will use Feedback’s digital infrastructure to facilitate patient-specific pathways through the CDCs, linking both primary and secondary care settings.

Feedback PLC (AIM:FDBK) announced it has signed a memorandum of understanding with Quest Teleradiology Solutions to develop strategic opportunities for Bleepa.

The pair will market the clinical communications platform in the large and growing Indian healthcare market, the UK and internationally.

Feedback’s (Feedback PLC (AIM:FDBK)) Tom Oakley speaks to Proactive London about the launch of their placing to raise at least GBP10mln to fund growth opportunities in the National Health Service (NHS) and other healthcare systems in the UK and abroad.

The funding proceeds will be used to develop Feedback’s CareLocker product and its Bleepa platform, to accelerate growth in the UK and manage overseas operations, to undertake a tuberculosis screening pilot study in India and to explore wider market opportunities in the country.